# Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)

> **NCT02258217** · NA · COMPLETED · sponsor: **OhioHealth** · enrollment: 30 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** Acthar

## Key facts

- **NCT ID:** NCT02258217
- **Lead sponsor:** OhioHealth
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-06-24
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02258217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02258217, "Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02258217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*